ANTIBODY TARGETING B CELL MATURATION ANTIGEN AND RELATED PRODUCTS THEREOF AND MEDICAL APPLICATIONS

NOVEL PROTEINS AND NUCLEIC ACID SEQUENCES AND USE THEREOF IN THE PROPHYLAXIS AND/OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHIES

HV1 MODULATORS AND USES

AFFINITY-ENHANCED MONMERIC STREPTAVIDIN CHIMERIC ANTIGEN RECEPTOR (CAR)

LAT ACTIVATING CHIMERIC ANTIGEN RECEPTOR T CELLS AND METHODS OF USE THEREOF

LAMP Constructs

MULTISPECIFIC BINDERS OF TGFBeta-SUPERFAMILY LIGANDS AND USES THEREOF

FAST ACTING SNARE-CLEAVING ENZYMES

ANTIGEN BINDING POLYPEPTIDES

ANTI-CD94 ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF

CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T) FOR THE TREATMENT OF CANCER

NOVEL GENE ARMORING

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

MODIFIED T CELLS AND USES THEREOF

MULTIVALENT OSPA POLYPEPTIDES AND METHODS AND USES RELATING THERETO

MODIFIED HUMAN CYTOMEGALOVIRUS PROTEINS

VACCINE COMPOSITIONS

ENGINEERING B CELLS TO EXPRESS CHIMERIC ANTIGEN RECEPTORS (CARS) AND USES THEREOF FOR T CELL INDEPENDENT ACTIVATION

Construction Method and Use of Novel Bispecific Chimeric Antigen Receptor (CAR)

PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF

BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES THEREOF

CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR INTERLEUKIN-23 RECEPTOR

CHIMERIC BAIT RECEPTORS AND USES THEREOF

GRANULIN/EPITHELIN MODULES AND COMBINATIONS THEREOF TO TREAT NEURODEGENERATIVE DISEASE

DNVSIG3 AND DNVSIG8 RECEPTORS AND METHODS OF USING THE SAME

VECTOR CONSTRUCTS FOR DELIVERY OF NUCLEIC ACIDS ENCODING THERAPEUTIC ANTI-IGF-1R ANTIBODIES AND METHODS OF USING THE SAME

NUCLEIC ACID MOLECULE ENCODING CAR AND VECTOR COMPRISING THE SAME, IMMUNE CELL INCLUDING CAR AND PHARMACEUTICAL COMPOSITION COMPRISING THE CELL, METHOD FOR IMPROVING CYTOTOXIC ACTIVITY, AND METHOD FOR PRODUCING IMMUNE CELL INCLUDING CAR

GENERATION OF CHIMERIC ANTIGEN RECEPTOR mRNA MOLECULES FOR EXPRESSION IN PRIMARY NK CELLS

Compositions and Methods for Treating Cancer with Anti-CD19/CD22 Immunotherapy

Method of Redirecting T Cells to Treat HIV Infection

MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY

HUMAN CYTOMEGALOVIRUS RNA VACCINES

SELECTIVELY CONTROLLABLE CLEAVABLE LINKERS

ANTI-PTK7 IMMUNE CELL CANCER THERAPY

ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A TRANSCRIPTION FACTOR AND A HEAT SHOCK PROTEIN 90 BINDING DOMAIN

MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS

METHODS FOR PRODUCTION OF THERAPEUTIC IMMUNE CELLS HAVING ENHANCED METABOLIC FITNESS AND COMPOSITIONS THEREOF

CATENATED VAR2CSA RECOMBINANT PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR (CAR) VECTORS AND LIBRARIES AND METHODS OF HIGH THROUGHPUT CAR SCREENING

COMPOSITIONS COMPRISING TRUNCATED INTERLEUKIN-33 AND INTERLEUKIN-2

Use of dual-target CAR-T cells in treating B-cell autoimmune diseases

ANTI-CD84 ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS

CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES THEREOF

HIGH AFFINITY B7-H6 ANTIBODIES AND ANTIBODY FRAGMENTS

PHENOTYPIC MARKERS FOR CELL THERAPY AND RELATED METHODS

Immunosuppressive Antigen-Specific Chimeric Antigen Receptor Treg Cells for Prevention and/or Treatment of Autoimmune and Alloimmune Disorders

USE OF INTERFERON AS AN ADJUVANT IN VACCINES

COMPOSITIONS AND METHODS FOR EXPRESSING ANTIGENS ON CELL MEMBRANE

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein

Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells

CONSTITUTIVELY ACTIVE CHIMERIC CYTOKINE RECEPTORS

FUSION PROTEINS FOR INHIBITING ANGIOGENESIS

FULLY HUMAN ANTIBODY TARGETING GPRC5D AND CHIMERIC ANTIGEN RECEPTOR (CAR) AND USE THEREOF

ANTI-B7H6 SCFV ANTIBODY, ITS CODING GENES AND THE APPLICATION THEREOF

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

TRANSMEMBRANE NEOANTIGENIC PEPTIDES

Recombinant Interleukin 12 Construct and Uses Thereof

MULTICISTRONIC CHIMERIC PROTEIN EXPRESSION SYSTEMS

CD7-CAR-T CELL, ITS PREPARATION METHOD AND THE APPLICATION THEREOF

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF MAKING AND USING THEREOF

BLOCKING AND NON-BLOCKING SINGLE DOMAIN ANTIBODIES AND USES THEREOF

ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES

IMMUNE CELL COMPOSITIONS AND METHODS OF USE

CHIMERIC SWITCH RECEPTORS IN NK CELLS

ANTI-CD276 AND ANTI-CD99 LOGIC GATED CHIMERIC ANTIGEN RECEPTORS FOR THE TREATMENT OF CANCER

IL-10 Monomer Fusion Protein and Use thereof

RNA ENCODING PEPTIDOGLYCAN HYDROLASE AND USE THEREOF FOR TREATING BACTERIAL INFECTION

ANTIGEN-BINDING PROTEINS TARGETING MELANOMA DIFFERENTIATION ANTIGENS AND USES THEREOF

HUMANIZED ANTI-MUC1* ANTIBODIES

CD79A CHIMERIC ANTIGEN RECEPTORS

HUMAN ALPHA-FOLATE RECEPTOR CHIMERIC ANTIGEN RECEPTOR

METHOD FOR PRODUCING CULTURED MEAT

CELLS EXPRESSING AN ANTI-MESOTHELIN CAR

Xylanase Variants

DESTABILISING DOMAINS FOR CONDITIONALLY STABILISING A PROTEIN

METHODS AND COMPOSITIONS FOR MODULATING CAR-T ACTIVITY

INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE

TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME

CONSTRUCTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) AND USES THEREOF

HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

COMPOSITIONS AND METHODS FOR IMPROVED T CELLS

CHIMERIC ANTIGEN RECEPTORS

CYTOKINE-IMMUNORECEPTOR FUSION PROTEINS AND USES THEREOF

Cell signaling complexes and uses thereof

NATURAL KILLER CELL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

ADOPTIVE CELLULAR THERAPY

THERAPEUTIC TREATMENT OF SKIN DISEASE WITH RECOMBINANT COMMENSAL SKIN MICROORGANISMS

RECOMBINANT SACCHAROMYCES CEREVISIAE STRAINS FOR ENZYMATIC HYDROLYSIS OF BIOPLASTIC POLYMERS

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF MAKING

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

NUCLEIC ACID MOLECULES, FUSION PROTEINS, AND MRNA VACCINES WITH ENHANCED ANTIGEN PRESENTATION BY RECRUITING LIGANDS

RECOMBINANT THYROID-STIMULATING HORMONE RECEPTOR PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF

UNIVERSAL STEM CELL AND USES THEREOF

Chimeric Natural Killer Cell Receptors and Method of Using Thereof

COMPOSITIONS AND METHODS OF MUSCLE SPECIFIC KINASE CHIMERIC AUTOANTIBODY RECEPTOR CELLS

Modified Cell, And Preparation Method Therefor and Use Thereof

CHIMERIC ANTIGEN RECEPTOR WITH ENDOGENOUS PROTEIN MOLECULE REPLACING SINGLE DOMAIN ANTIBODY

BCMA CHIMERIC ANTIGEN RECEPTORS

IL5RA CELL SURFACE MARKERS

CAR-INKT WITH HIGH AMPLIFICATION, SURVIVAL CAPACITY AND TUMOR KILLING EFFECT AND USE THEREOF

MOLECULES THAT BIND TO CD94/NKG2A HETERODIMER POLYPEPTIDES

RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING IT AND USES THEREOF

ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME

CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF

Novel Recombinant Cell Surface Markers

T-Cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use Thereof

ANTAGONIST FUSION POLYPEPTIDES

ENGINEERING NK CELLS WITH A CAR CONSTRUCT WITH OPTIMAL SIGNALING

CHIMERIC ANTIGEN RECEPTOR IMMUNE CELL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

ENGINEERED CYTOKINE RECEPTORS FOR TUNABLE ADOPTIVE CELL THERAPY

CELL

MND PROMOTER CHIMERIC ANTIGEN RECEPTORS

Chemically Inducible Heterodimerizing System and A Method For Generation Thereof

COMPOSITIONS AND METHODS FOR THE TREATMENT OF P53-MEDIATED CANCERS

ACTIVE LOW MOLECULAR WEIGHT VARIANTS OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2)

ANTI-CD30 ANTIBODY AND CHIMERIC ANTIGEN RECEPTOR COMPRISING THEREOF

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

GENE SEQUENCE CONSTRUCT FOR GENE THERAPY FOR HIV INFECTION

CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES THAT RE-DIRECT GLUCOSE METABOLITES OUT OF THE GLYCOLYSIS PATHWAY AND THERAPEUTIC USES THEREOF

ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF

NUCLEIC ACID CONSTRUCT

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

COMPOSITIONS AND METHODS OF PHOSPHOLIPASE A2 RECEPTOR CHIMERIC AUTOANTIBODY RECEPTOR T CELLS

GENETICALLY ENGINEERED CELLS AND USES THEREOF

Cell Selection Methods and Related Compositions

CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING KREBS CYCLE AND THERAPEUTIC USES THEREOF

UNIVERSAL CAR-T CELL TARGETING IL13RALPHA2, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS

COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO B CELL RECEPTORS

CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND USES THEREOF

FUSION PROTEIN BETWEEN SHORT FORM ROD-DERIVED CONE VIABILITY FACTOR AND A HYDROPHILIC PEPTIDE

GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT

COMPOSITIONS, DEVICES AND METHODS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE

CELLS MODIFIED BY A CAS12I POLYPEPTIDE

MODIFIED SIGNAL PEPTIDE

MODIFICATION OF EPOR-ENCODING NUCLEIC ACIDS

Engineered Expression of Cell Surface and Secreted Sialidase by CAR T Cells for Increased Efficacy in Solid Tumors

MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

SIRP1a TARGETED CHIMERIC PROTEINS AND USES THEREOF

SALVAGE CHIMERIC ANTIGEN RECEPTOR SYSTEMS

MURINE ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATING HIV/AIDS WITH IMMUNOTHERAPY

CHIMERIC ENGULFMENT RECEPTOR MOLECULES

SENESCENCE TREATMENT with IL-15-BASED FUSIONS to IL-7 and IL-21

CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

Universal Receptor Immune Cell Therapy

CAR T CELL THERAPY AND IFN GAMMA

INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE

GENETICALLY MODIFIED NATURAL KILLER CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY

ANTI-PD-L1 AND IL-2 CYTOKINES

DIMERIC PROTEIN COMPLEXES AND USES THEREOF

COMPOSITIONS AND METHODS FOR MULTIVALENT SURFACE DISPLAY ON ENVELOPED PARTICLES

Polynucleotide molecules used for the prevention or treatment of HPV infection related diseases

MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH

HIGH SELECTIVE CD229 ANTIGEN BINDING DOMAINS AND METHODS OF USE

CHIMERIC CYTOKINE RECEPTOR

GENETICALLY MODIFIED PROBIOTICS FOR ORAL DELIVERY OF RENIN-ANGIOTENSIN RELATED THERAPEUTIC PROTEINS AND PEPTIDES

ENGINEERED IMMUNE CELL THAT SPECIFICALLY TARGETS MESOTHELIN AND USES THEREOF

VACCINE COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN-SPECIFIC VACCINATION

TEMPERATURE-CONTROLLABLE, RNA IMMUNOTHERAPEUTIC FOR CANCER

CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY PLATFORM

MODIFIED IMMUNE CELLS EXPRESSING TLR RECEPTORS

HIGH EFFICIENCY PRODUCTION OF CANNABIDIOLIC ACID

USE OF CD4-TARGETED VIRAL VECTORS

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

INTRACELLULAR ANTIBODY AND PREPARATION METHOD AND USE THEREOF

CHIMERIC ANTIGEN RECEPTORS (CAR) FOR B CELL MALIGNANCIES

VECTOR ENCODING ROD-DERIVED CONE VIABILITY FACTOR AND HUMAN IGK SIGNAL SEQUENCE

CCDC7 CIRCULAR RNA ENCODED PROTEIN INHIBITS THE PROGRESSION OF PROSTATE CANCER BY UP-REGULATING FLRT3

OPTIMIZING T CELL DIFFERENTIATION STATE WITH MICRORNAS

ENGINEERED T CELL RECEPTORS FUSED TO BINDING DOMAINS FROM ANTIBODIES

CHIMERIC ANTIGEN RECEPTOR

Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule

Fusion Proteins for Dephosphorylating Proteins that Regulate T Cell Activation through the TCR Signaling Pathway

ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF

NOVEL CLDN 18.2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

METHOD FOR SURFACE EXPRESSION OF MEMBRANE PROTEINS THAT HAVE A CYTOPLASMIC C-TERMINAL TAIL

MODULATION OF BCL-2 TO ENHANCE CHIMERIC ANTIGEN RECEPTOR CANCER IMMUNOTHERAPY EFFICACY

NOVEL CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELLS EXPRESSING SAME

TRUNCATED INFLUENZA NEURAMINIDASE AND METHODS OF USING THE SAME

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND USES THEREOF

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

ANTI-HER2 CAR NK CELLS, METHODS OF THEIR PRODUCTION AND USES THEREOF

BACTERIAL STRAIN FOR RELEASING A RECOMBINANT PROTEIN IN A FERMENTATION METHOD

ENGINEERED IMMUNE CELLS TARGETING BCMA AND THEIR USES THEREOF

PEPTIDES AND ANTIGEN BINDING PROTEINS FOR USE IN IMMUNOTHERAPY AGAINST FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (FL-HCC) AND OTHER CANCERS

METASTATIC BRAIN TUMOR TARGETING PEPTIDES

CAR T/NK-CELLS FOR USE IN THE TREATMENT OF INVASIVE FUNGAL INFECTIONS

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

CHIMERIC ANTIGEN RECEPTOR TO TARGET TROP-2-POSITIVE CANCERS

CD3-EXPRESSING NATURAL KILLER CELLS WITH ENHANCED FUNCTION FOR ADOPTIVE IMMUNOTHERAPY

FLT3-BINDING CHIMERIC ANTIGEN RECEPTORS, CELLS, AND USES THEREOF

CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF

TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY

PEPTIDES FOR IMMUNOTHERAPY

NOVEL CHIMERIC RECEPTOR COMPOSITION, RECOMBINANT VECTOR, CELL, AND APPLICATION THEREOF

ENGINEERED NATURAL KILLER (NK) CELLS AND RELATED METHODS

Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy

TAU-SPECIFIC ANTIBODY GENE THERAPY COMPOSITIONS, METHODS AND USES THEREOF

EGFR-TARGETING CHIMERIC ANTIGEN RECEPTOR

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

SYNTHETICALLY EVOLVED DNA CONSTRUCTS FOR REGULATING SIGNAL PEPTIDE PERFORMANCE AS WELL AS VECTORS, HOST CELLS AND RECOMBINANT PROTEINS THEREOF

Compositions and Methods for Treating Fabry Disease

CHIMERIC HLA ACCESSORY RECEPTOR

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS

SELF-POLARIZING IMMUNE CELLS

TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE

RAPAMYCIN RESISTANT CELLS

ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS

CHIMERIC ANTIGEN RECEPTORS, COMPOSITIONS, AND METHODS

HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

ANTIGEN-BINDING PROTEINS TARGETING CD56 AND METHODS OF PRODUCING THEREOF

RECOMBINANT PROTEINS

COMPOSITIONS AND METHODS OF RIBONUCLEIC ACID RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES

D2C7 EGFR AND EGFR VIII BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS AND METHODS OF MAKING AND USING SAME

MESOTHELIN ISOFORM BINDING MOLECULES AND CHIMERIC PD1 RECEPTOR MOLECULES, CELLS CONTAINING THE SAME AND USES THEREOF

Methods of Treating T Cell Exhaustion by Inhibiting or Modulating T Cell Receptor Signaling

PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE

BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME

BAFF-R ANTIBODIES AND USES THEREOF

LONG-ACTING RECOMBINANT HUMAN INTERLEUKIN-2 FUSION PROTEIN, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

NON-NATURAL NKG2D RECEPTORS THAT DO NOT DIRECTLY SIGNAL THE CELLS TO WHICH THEY ARE ATTACHED

PREPARATION AND APPLICATION OF CHIMERIC ANTIGEN RECEPTOR IMMUNE CELL CONSTRUCTED ON BASIS OF GRANZYME B

ANTI-CD72 CHIMERIC RECEPTORS AND USES THEREOF

CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY

ANTIBODIES TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

COMPOSITION COMPRISING RECOMBINANT Gplba RECEPTOR PROTEIN

MODIFIED INSULIN AND GLUCOKINASE NUCLEIC ACIDS FOR TREATING DIABETES

PREPARATION AND APPLICATION OF CHIMERIC ANTIGEN RECEPTOR IMMUNE CELL CONSTRUCTED ON BASIS OF LOX1

ARMED CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

COMBINATION OF PRAME SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS

LEADER PEPTIDES AND POLYNUCLEOTIDES ENCODING THE SAME

COMPOSITIONS AND METHODS FOR ISOLATING T CELL RECEPTORS (TCRS) AND CELLS EXPRESSING THE SAME

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy

NOVEL ANTI-CLAUDIN18 ANTIBODIES

FUSION PROTEINS COMPRISING SARS-COV-2 RECEPTOR BINDING DOMAIN

Antigen-binding polypeptide targeting B7H3 and application thereof

CAR-T CELL THERAPY FOR TRIPLE NEGATIVE BREAST CANCER

TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES

Modified Chimeric Antigen Receptor and Use thereof

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY

GPRC5D CHIMERIC ANTIGEN RECEPTORS AND CELLS EXPRESSING THE SAME

NOVEL RECEPTORS FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION

METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE

ENGINEERED IMMUNE CELLS, COMPOSITIONS AND METHODS THEREOF

CD19-Directed Chimeric Antigen Receptor Constructs

ANTIBODY-BASED ANTIVIRUS COMPOSITIONS AND METHODS OF USE

CHIMERIC POLYPEPTIDES AND METHODS OF USE

CD33 SPECIFIC CHIMERIC ANTIGEN RECEPTORS

Membrane-bound IL-12 for cellular immunotherapy

DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION

MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY

GENETICALLY MODIFIED CLOSTRIDIUM STRAINS EXPRESSING RECOMBINANT ANTIGENS AND USES THEREOF

ANTIGEN RECOGNIZING RECEPTORS TARGETING DLL3 AND USES THEREOF

DUAL EGFR-MUCI CHIMERIC CANTIGEN RECEPTOR T CELLS

MODIFIED IMMUNE CELLS AND USES THEREOF

COMPOSITIONS AND METHODS FOR T-CELL AND CYTOKINE ACTIVATION

BI-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND GENETICALLY ENGINEERED IMMUNE CELLS EXPRESSING SUCH

FULLY HUMAN ANTIBODY FOR HUMAN B7H3, CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

SYNTHETIC PROTEIN FOR INDUCING IMMUNE TOLERANCE

MONOBODY-BASED CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELL INCLUDING SAME

DNase I Variants, Compositions, Methods, and Kits

A PLANT PRODUCED ANTI-EGFR MABS WITH SPECIFIC GLYCOSYLATION TO IMPROVE THE EFFICACY AGAINST CANCER

HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION

Ligand discovery and gene delivery via retroviral surface display

ARENAVIRUSES AS VECTORS

DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY

ANTIBODIES TARGETING BAFF-R AND USE THEREOF

mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS

THERAPEUTIC AGENTS

Molecules for organelle-specific protein delivery

INTERGENERIC ENDOSPORE DISPLAY PLATFORMS, PRODUCTS AND METHODS

CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR BAFF-R AND CD19 AND METHODS AND USES THEREOF

TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN

METHOD FOR EDITING PLANT GENOME

EXPRESSION AND ENHANCED SECRETION OF ACTIVE MORINGA OLEIFERA COAGULANT PROTEIN IN BACILLUS

CHIMERIC POLYPEPTIDES, NUCLEIC ACID MOLECULES, CELLS, AND RELATED METHODS

ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS

Novel Anti-CD5 Chimeric Antigen Receptor and Immune Cell Expressing Same

CHIMERIC ANTIGEN RECEPTORS TARGETING SPLICE VARIANTS OF THE EXTRACELLULAR MATRIX PROTEINS TENASCIN C (TNC) AND PROCOLLAGEN 11A1 (COL11A1)

COMPOSITIONS AND METHODS FOR TARGETING INFLAMMATORY OR ACTIVATED CELLS AND TREATING OR AMELIORATING INFLAMMATORY CONDITIONS AND PAIN

PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION

MODIFIED IMMUNE CELLS AND USES THEREOF

METHODS FOR REDUCING LOW MOLECULAR WEIGHT SPECIES OF RECOMBINANTLY-PRODUCED PROTEINS

COMPOSITIONS AND METHODS FOR DELIVERY AND EXPRESSION OF SMALL INHIBITORY PEPTIDES AND USE THEREOF

EGFRVIII BINDING PROTEINS

ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME

PLANT CELL LINE FOR PRODUCING ALBUMIN AT HIGH EFFICIENCY AND USE THEREOF

THERAPEUTIC COMPOSITIONS COMPRISING MICROBE-TARGETING MOLECULES AND THEIR USE IN METHODS OF PREVENTING AND TREATING INFECTIOUS DISEASE

SIGNAL PEPTIDES

COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY

ANTIGEN RECOGNIZING RECEPTORS TARGETING CD33 AND USES THEREOF